Cover Image
Market Research Report
Product code 
1014942

Middle East and Africa Gene Synthesis Market- Industry Trends and Forecast to 2028

Published: | Data Bridge Market Research Private Limited | 150 Pages | Delivery time: 3-5 business days

Price

Back to Top
Middle East and Africa Gene Synthesis Market- Industry Trends and Forecast to 2028
Published: April 1, 2021
Data Bridge Market Research Private Limited
Content info: 150 Pages
Delivery time: 3-5 business days
  • ALL
  • Description
  • Table of Contents
Description

Middle East and Africa gene synthesis market is projected to register a CAGR of 27.0% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.

Market Segmentation:

Middle East and Africa Gene Synthesis Market, By Product & Services (Software & Services, Consumables, Synthesizer), Gene Type (Standard Gene, Complex Gene, Express Gene, Others), Product Type (Custom Gene Synthesis, Gene Library Synthesis), Application (Synthetic Biology, Genetic Engineering, Therapeutic Antibodies, Vaccine Design, Others), Method (PCR Based Enzyme Synthesis, CHIP Based DNA Synthesis, Solid Phase Synthesis), End User (Academic & Research Institutes, Biotech & Pharmaceutical Companies, Diagnostic Laboratories, Other), Distribution Channel (Direct Tender, Online Distribution, Third Party Distributors), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel And Rest Of Middle East And Africa) Industry Trends and Forecast To 2028

Some of the major factors contributing to the growth of the Middle East and Africa gene synthesis market are:

  • Rising adoption of gene therapy
  • Growing interest of gene synthesis in field of molecular biology

Market Players:

The key market players for Middle East and Africa gene synthesis market are listed below:

  • Eurofins Genomics
  • Merck KGaA
  • Synbio Technologies
  • Thermo Fisher Scientific Inc
  • Genscript
  • General Biosystems
  • Twist Bioscience
  • Bio-synthesis Inc
  • LGC Limited
  • Eurofins Scientific
  • Macrogen, Inc
  • Origene Technologies, INC.
  • Proteo Genix
  • Integrated DNA Technologies, Inc. (a subsidiary of Danaher)
  • Kaneka Eurogentec S.A.
Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 PRODUCT & SERVICES LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET APPLICATION COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: REGULATIONS

  • 4.1 OTHER STANDARD REGULATIONS IMPLEMENTED WORLDWIDE
  • 4.2 REGULATIONS RELATED TO BIODIVERSITY WHILE USING SYNTHETIC BIOLOGY

5 MARKET OVERVIEW

  • 5.1 DRIVERS
    • 5.1.1 RISING PREVALENCE OF CHRONIC INFECTIOUS DISEASES
    • 5.1.2 RISING ADOPTION OF GENE THERAPY
    • 5.1.3 GROWING INTEREST OF GENE SYNTHESIS IN THE FIELD OF MOLECULAR BIOLOGY
    • 5.1.4 FAVORABLE GOVERNMENT INITIATIVES
    • 5.1.5 EXPANDING FIELD OF SYNTHETIC BIOLOGY
  • 5.2 RESTRAINTS
    • 5.2.1 ETHICAL ISSUES ASSOCIATED WITH GENETIC ENGINEERING
    • 5.2.2 THREAT IMPOSED TO ECOSYSTEM AND BIODIVERSITY
    • 5.2.3 LACK OF TRAINED PROFESSIONALS
    • 5.2.4 TECHNICAL LIMITATION ACROSS PRODUCTION PROCESS
  • 5.3 OPPORTUNITIES
    • 5.3.1 INCREASED FUNDING TOWARDS GENOMICS
    • 5.3.2 TECHNOLOGICAL ADVANCEMENTS
    • 5.3.3 INCREASING DEMAND OF PERSONALIZED MEDICINES
  • 5.4 CHALLENGES
    • 5.4.1 LONG APPROVAL PROCESS
    • 5.4.2 LACK OF WELL DEFINED PATENT SYSTEM

6 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET

  • 6.1 IMPACT ON SUPPLY CHAIN
  • 6.2 IMPACT ON DEMAND
  • 6.3 STRATEGIC DECISION FOR MANUFACTURERS
  • 6.4 CONCLUSION

7 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES

  • 7.1 OVERVIEW
  • 7.2 SOFTWARE & SERVICES
  • 7.3 CONSUMBLES
    • 7.3.1 REAGENTS
    • 7.3.2 ASSAYS
    • 7.3.3 PROBES & DYES
    • 7.3.4 OTHERS
  • 7.4 SYNTHESIZER
    • 7.4.1 COLUMN-BASED SYNTHESIZERS
    • 7.4.2 MICROARRAY-BASED SYNTHESIZERS

8 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE

  • 8.1 OVERVIEW
  • 8.2 STANDARD GENE
  • 8.3 COMPLEX GENE
  • 8.4 EXPRESS GENE
  • 8.5 OTHERS

9 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY PRODUCT TYPE

  • 9.1 OVERVIEW
  • 9.2 CUSTOM GENE SYNTHESIS
  • 9.3 GENE LIBRARY SYNTHESIS

10 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY APPLICATION

  • 10.1 OVERVIEW
  • 10.2 SYNTHETIC BIOLOGY
  • 10.3 GENETIC ENGINEERING
  • 10.4 THERAPEUTIC ANTIBODIES
  • 10.5 VACCINE DESIGN
  • 10.6 OTHERS

11 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY METHOD

  • 11.1 OVERVIEW
  • 11.2 PCR BASED ENZYME SYNTHESIS
  • 11.3 CHIP BASED DNA SYNTHESIS
  • 11.4 SOLID BASED SYNTHESIS

12 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY END USER

  • 12.1 OVERVIEW
  • 12.2 ACADEMIC & RESEARCH INSTITUTE
  • 12.3 BIOTECH & PHARMACEUTICAL COMPANIES
  • 12.4 DIAGNOSTIC LABORATORIES
  • 12.5 OTHERS

13 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL

  • 13.1 OVERVIEW
  • 13.2 DIRECT TENDER
  • 13.3 ONLINE DISTRIBUTION
  • 13.4 THIRD PARTY DISTRIBUTORS

14 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET BY GEOGRAPHY

  • 14.1 MIDDLE EAST AND AFRICA
    • 14.1.1 SAUDI ARAB
    • 14.1.2 SOUTH AFRICA
    • 14.1.3 UAE
    • 14.1.4 ISRAEL
    • 14.1.5 EGYPT
    • 14.1.6 REST OF MIDDLE EAST AND AFRICA

15 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, COMPANY LANDSCAPE

  • 15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

16 SWOT ANALYSIS

17 COMPANY PROFILE

  • 17.1 INTEGRATED DNA TECHNOLOGIES, INC. (A SUBSIDIARY OF DANAHER)
    • 17.1.1 COMPANY SNAPSHOT
    • 17.1.2 REVENUE ANALYSIS
    • 17.1.3 COMPANY SHARE ANALYSIS
    • 17.1.4 PRODUCT PORTFOLIO
    • 17.1.5 RECENT DEVELOPMENTS
  • 17.2 THERMO FISHER SCIENTIFIC INC.
    • 17.2.1 COMPANY SNAPSHOT
    • 17.2.2 REVENUE ANALYSIS
    • 17.2.3 COMPANY SHARE ANALYSIS
    • 17.2.4 PRODUCT PORTFOLIO
    • 17.2.5 RECENT DEVELOPMENTS
  • 17.3 MERCK KGAA
    • 17.3.1 COMPANY SNAPSHOT
    • 17.3.2 REVENUE ANALYSIS
    • 17.3.3 COMPANY SHARE ANALYSIS
    • 17.3.4 PRODUCT PORTFOLIO
    • 17.3.5 RECENT DEVELOPMENTS
  • 17.4 EUROFINS SCIENTIFIC
    • 17.4.1 COMPANY SNAPSHOT
    • 17.4.2 REVENUE ANALYSIS
    • 17.4.3 COMPANY SHARE ANALYSIS
    • 17.4.4 SERVICE PORTFOLIO
    • 17.4.5 RECENT DEVELOPMENT
  • 17.5 BIO BASIC INC.
    • 17.5.1 COMPANY SNAPSHOT
    • 17.5.2 PRODUCT PORTFOLIO
    • 17.5.3 RECENT DEVELOPMENTS
  • 17.6 KANEKA EUROGENTEC S.A.
    • 17.6.1 COMPANY SNAPSHOT
    • 17.6.2 PRODUCT PORTFOLIO
    • 17.6.3 RECENT DEVELOPMENTS
  • 17.7 GENEWIZ (A SUBSIDIARY OF BROOKS AUTOMATION, INC.)
    • 17.7.1 COMPANY SNAPSHOT
    • 17.7.2 REVENUE ANALYSIS
    • 17.7.3 SERVICE PORTFOLIO
    • 17.7.4 RECENT DEVELOPMENTS
  • 17.8 LGC LIMITED
    • 17.8.1 COMPANY SNAPSHOT
    • 17.8.2 PRODUCT PORTFOLIO
    • 17.8.3 RECENT DEVELOPMENTS
  • 17.9 CREATIVE BIOGENE
    • 17.9.1 COMPANY SNAPSHOT
    • 17.9.2 SERVICE PORTFOLIO
    • 17.9.3 RECENT DEVELOPMENT
  • 17.10 GENSCRIPT
    • 17.10.1 COMPANY SNAPSHOT
    • 17.10.2 REVENUE ANALYSIS
    • 17.10.3 REAGENT SERVICE PORTFOLIO
    • 17.10.4 RECENT DEVELOPMENT
  • 17.11 CODEX DNA, INC.
    • 17.11.1 COMPANY SNAPSHOT
    • 17.11.2 PRODUCT PORTFOLIO
    • 17.11.3 RECENT DEVELOPMENTS
  • 17.12 BBI-LIFESCIENCES
    • 17.12.1 COMPANY SNAPSHOT
    • 17.12.2 REVENUE ANALYSIS
    • 17.12.3 PRODUCT PORTFOLIO
    • 17.12.4 RECENT DEVELOPMENT
  • 17.13 ALDEVRON
    • 17.13.1 COMPANY SNAPSHOT
    • 17.13.2 PRODUCT PORTFOLIO
    • 17.13.3 RECENT DEVELOPMENTS
  • 17.14 ATUM
    • 17.14.1 COMPANY SNAPSHOT
    • 17.14.2 SERVICE PORTFOLIO
    • 17.14.3 RECENT DEVELOPMENTS
  • 17.15 TWIST BIOSCIENCE
    • 17.15.1 COMPANY SNAPSHOT
    • 17.15.2 REVENUE ANALYSIS
    • 17.15.3 PRODUCT PORTFOLIO
    • 17.15.4 RECENT DEVELOPMENTS
  • 17.16 BIOCAT GMBH
    • 17.16.1 COMPANY SNAPSHOT
    • 17.16.2 PRODUCT PORTFOLIO
    • 17.16.3 RECENT DEVELOPMENT
  • 17.17 ATG:BIOSYNTHETICS GMBH
    • 17.17.1 COMPANY SNAPSHOT
    • 17.17.2 PRODUCT PORTFOLIO
    • 17.17.3 RECENT DEVELOPMENT
  • 17.18 EVONETIX
    • 17.18.1 COMPANY SNAPSHOT
    • 17.18.2 PLATFORM PORTFOLIO
    • 17.18.3 RECENT DEVELOPMENTS
  • 17.19 EXONBIO
    • 17.19.1 COMPANY SNAPSHOT
    • 17.19.2 SERVICE PORTFOLIO
    • 17.19.3 RECENT DEVELOPMENT
  • 17.20 TRENZYME GMBH
    • 17.20.1 COMPANY SNAPSHOT
    • 17.20.2 SERVICE PORTFOLIO
    • 17.20.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 2 MIDDLE EAST AND AFRICA SOFTWARE & SERVICES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 3 MIDDLE EAST AND AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 4 MIDDLE EAST AND AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 5 MIDDLE EAST AND AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 6 MIDDLE EAST AND AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 7 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 8 MIDDLE EAST AND AFRICA STANDARD GENE IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 9 MIDDLE EAST AND AFRICA COMPLEX GENE IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 10 MIDDLE EAST AND AFRICA EXPRESS GENE IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 11 MIDDLE EAST AND AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 12 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 13 MIDDLE EAST AND AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 14 MIDDLE EAST AND AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 15 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 16 MIDDLE EAST AND AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 17 MIDDLE EAST AND AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 18 MIDDLE EAST AND AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 19 MIDDLE EAST AND AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 20 MIDDLE EAST AND AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 21 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2017-2028 (USD MILLION)
  • TABLE 22 MIDDLE EAST AND AFRICA PCR BASED ENZYME SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 23 MIDDLE EAST AND AFRICA CHIP BASED DNA SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 24 MIDDLE EAST AND AFRICA SOLID PAHSE SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 25 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY END USER, 2017-2028 (USD MILLION)
  • TABLE 26 MIDDLE EAST AND AFRICA ACADEMIC & RESEARCH INSTITUTE IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 27 MIDDLE EAST AND AFRICA BIOTECH & PHARMACEUTICAL COMPANIES IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 28 MIDDLE EAST AND AFRICA DIAGNOSTIC LABORATORY IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 29 MIDDLE EAST AND AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 30 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2017-2028 (USD MILLION)
  • TABLE 31 MIDDLE EAST AND AFRICA DIRECT TENDER IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 32 MIDDLE EAST AND AFRICA ONLINE DISTRIBUTION IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 33 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTOR IN GENE SYNTHESIS MARKET, BY REGION, 2017-2028 (USD MILLION)
  • TABLE 34 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 35 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 36 MIDDLE EAST AND AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 37 MIDDLE EAST AND AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 38 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 39 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 40 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 41 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 42 MIDDLE EASTA AND AFRICA GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 44 SAUDI ARAB GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 45 SAUDI ARAB CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 46 SAUDI ARAB SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 47 SAUDI ARAB GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 48 SAUDI ARAB GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 49 SAUDI ARAB GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 50 SAUDI ARAB GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 51 SAUDI ARAB GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 52 SAUDI ARAB GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 53 SOUTH AFRICA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 54 SOUTH AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 55 SOUTH AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 56 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 57 SOUTH AFRICA GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 58 SOUTH AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 59 SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 60 SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 61 SOUTH AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 62 UAE GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 63 UAE CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 64 UAE SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 65 UAE GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 66 UAE GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 67 UAE GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 68 UAE GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 69 UAE GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 70 UAE GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 71 ISRAEL GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 72 ISRAEL CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 73 ISRAEL SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 74 ISRAEL GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 75 ISRAEL GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 76 ISRAEL GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 77 ISRAEL GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 78 ISRAEL GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 79 ISRAEL GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 80 EGYPT GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 81 EGYPT CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 82 EGYPT SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 83 EGYPT GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 84 EGYPT GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 85 EGYPT GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 86 EGYPT GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 87 EGYPT GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 88 EGYPT GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 89 REST OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES, 2019-2028 (USD MILLION)
  • TABLE 90 REST OF MIDDLE EAST AND AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 91 REST OF MIDDLE EAST AND AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY PRODUCT & SERVICES 2019-2028 (USD MILLION)
  • TABLE 92 REST OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2019-2028 (USD MILLION)
  • TABLE 93 REST OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
  • TABLE 94 REST OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 95 REST OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2019-2028 (USD MILLION)
  • TABLE 96 REST OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 97 REST OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: SEGMENTATION
  • FIGURE 2 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET : DATA TRIANGULATION
  • FIGURE 3 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: DROC ANALYSIS
  • FIGURE 4 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: MULTIVARIATE MODELLING
  • FIGURE 7 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 10 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 11 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: SEGMENTATION
  • FIGURE 12 RISING ADOPTION OF GENE THERAPY IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 13 SOFTWARE & SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET IN 2021 & 2028
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET
  • FIGURE 15 PEDIATRIC DEATHS CAUSE BY INFLUENZA (2017-2020) IN THE U.S.
  • FIGURE 16 MIDDLE EAST AND AFRICA PREVALENCE OF HBV INFECTION (WORLDWIDE, 2018)
  • FIGURE 17 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT & SERVICES, 2020
  • FIGURE 18 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT & SERVICES, 2020-2028 (USD MILLION)
  • FIGURE 19 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT & SERVICES, CAGR (2020-2028).
  • FIGURE 20 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
  • FIGURE 21 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2020
  • FIGURE 22 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2020-2028 (USD MILLION)
  • FIGURE 23 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, CAGR (2020-2028)
  • FIGURE 24 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, LIFELINE CURVE
  • FIGURE 25 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE, 2020
  • FIGURE 26 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION)
  • FIGURE 27 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE, CAGR (2020-2028)
  • FIGURE 28 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
  • FIGURE 29 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2020
  • FIGURE 30 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
  • FIGURE 31 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, CAGR (2020-2028)
  • FIGURE 32 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 33 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2020
  • FIGURE 34 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2020-2028 (USD MILLION)
  • FIGURE 35 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY METHOD, CAGR (2020-2028)
  • FIGURE 36 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY METHOD, LIFELINE CURVE
  • FIGURE 37 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY END USER, 2020
  • FIGURE 38 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY END USER , 2020-2028 (USD MILLION)
  • FIGURE 39 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY END USER, CAGR (2020-2028)
  • FIGURE 40 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 41 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 42 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
  • FIGURE 43 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)
  • FIGURE 44 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 45 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: SNAPSHOT (2020)
  • FIGURE 46 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2020)
  • FIGURE 47 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 48 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 49 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: BY PRODUCT TYPE (2021-2028)
  • FIGURE 50 MIDDLE EAST AND AFRICA GENE SYNTHESIS MARKET: COMPANY SHARE 2020 (%)